BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1549357)

  • 1. Identification of three essential regions of hepatitis B virus X protein for trans-activation function.
    Arii M; Takada S; Koike K
    Oncogene; 1992 Mar; 7(3):397-403. PubMed ID: 1549357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The conserved amino-terminal region (amino acids 1-20) of the hepatitis B virus X protein shows a transrepression function.
    Misra KP; Mukherji A; Kumar V
    Virus Res; 2004 Oct; 105(2):157-65. PubMed ID: 15351489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of hepatitis B virus transactivator X: implication of the leucine zipper-like region and C-terminal seven conserved amino acids in functional regions.
    Kim YH; Kang SK; Lee YI
    Biochem Biophys Res Commun; 1993 Dec; 197(2):894-903. PubMed ID: 8267629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator.
    Kekulé AS; Lauer U; Meyer M; Caselmann WH; Hofschneider PH; Koshy R
    Nature; 1990 Feb; 343(6257):457-61. PubMed ID: 2153938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transactivation of cellular promoters by an integrated hepatitis B virus DNA.
    Yamamoto S; Nakatake H; Kawamoto S; Takimoto M; Koshy R; Matsubara K
    Biochem Biophys Res Commun; 1993 Apr; 192(1):111-8. PubMed ID: 8476412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of X protein on transactivation of hepatitis B virus promoters and on viral replication.
    Nakatake H; Chisaka O; Yamamoto S; Matsubara K; Koshy R
    Virology; 1993 Aug; 195(2):305-14. PubMed ID: 8337816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three sites of the hepatitis B virus X protein cooperatively interact with cellular proteins.
    Takada S; Koike K
    Virology; 1994 Dec; 205(2):503-10. PubMed ID: 7975252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of hepatocarcinogenesis by hepatitis B virus].
    Takada S; Koike K
    Nihon Rinsho; 1993 Feb; 51(2):364-9. PubMed ID: 8385238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein.
    Fukuma T; Enomoto N; Marumo F; Sato C
    Hepatology; 1998 Oct; 28(4):1147-53. PubMed ID: 9755255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues.
    Tu H; Bonura C; Giannini C; Mouly H; Soussan P; Kew M; Paterlini-Bréchot P; Bréchot C; Kremsdorf D
    Cancer Res; 2001 Nov; 61(21):7803-10. PubMed ID: 11691796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state.
    Wollersheim M; Debelka U; Hofschneider PH
    Oncogene; 1988 Nov; 3(5):545-52. PubMed ID: 2856254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of integrated hepatitis B virus X variants in human hepatocellular carcinomas and its significance.
    Chen WN; Oon CJ; Leong AL; Koh S; Teng SW
    Biochem Biophys Res Commun; 2000 Oct; 276(3):885-92. PubMed ID: 11027564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-codon insertion mutations of the HBx define two separate regions necessary for its trans-activation function.
    Runkel L; Fischer M; Schaller H
    Virology; 1993 Dec; 197(2):529-36. PubMed ID: 8249276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [X protein variations of genotype B and C hepatitis B virus isolated from the patients with hepatocellular carcinoma].
    Xu X; Chen WN; Zheng DL; Huang QL; Lin X
    Ai Zheng; 2004 Jul; 23(7):756-61. PubMed ID: 15248907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of hepatitis B virus X protein with a serine protease, tryptase TL2 as an inhibitor.
    Takada S; Kido H; Fukutomi A; Mori T; Koike K
    Oncogene; 1994 Feb; 9(2):341-8. PubMed ID: 8290248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma.
    Yeh CT; Shen CH; Tai DI; Chu CM; Liaw YF
    Oncogene; 2000 Nov; 19(46):5213-20. PubMed ID: 11077437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a conserved peptide derived from Kunitz domain of hepatitis B virus x protein on the cell cycle and apoptosis of HepG2 cells via the proteasome pathway.
    Liu H; Ye L; Wang QW; Yan QX; Yu JM
    Chin Med J (Engl); 2009 Feb; 122(4):460-5. PubMed ID: 19302755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of specific amino acid residues in the acidic domain I of VSV phosphoprotein (P) converts a GAL4-P(I) hybrid into a transcriptional activator.
    Takacs AM; Perrine KG; Barik S; Banerjee AK
    New Biol; 1991 Jun; 3(6):581-91. PubMed ID: 1655011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4.
    Lee YI; Lee S; Lee Y; Bong YS; Hyun SW; Yoo YD; Kim SJ; Kim YW; Poo HR
    Oncogene; 1998 May; 16(18):2367-80. PubMed ID: 9620554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the DNA-binding and transcriptional activation functions of human Fli-1 protein.
    Rao VN; Ohno T; Prasad DD; Bhattacharya G; Reddy ES
    Oncogene; 1993 Aug; 8(8):2167-73. PubMed ID: 8336942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.